Auro Laboratories [AUROLAB] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

Auro Laboratories Limited

BSE
Loading...

Divi's Laboratories Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Auro Laboratories Limited wins in 11 metrics, Divi's Laboratories Ltd. wins in 8 metrics, with 0 ties. Auro Laboratories Limited appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Auro Laboratories Limited Divi's Laboratories Ltd. Better
P/E Ratio (TTM) 48.08 67.11 Auro Laboratories Limited
Price-to-Book Ratio 3.57 10.82 Auro Laboratories Limited
Debt-to-Equity Ratio 100.84 0.58 Divi's Laboratories Ltd.
PEG Ratio 0.01 4.63 Auro Laboratories Limited
EV/EBITDA 31.14 48.63 Auro Laboratories Limited
Profit Margin (TTM) 11.39% 24.04% Divi's Laboratories Ltd.
Operating Margin (TTM) 32.83% 29.65% Auro Laboratories Limited
EBITDA Margin (TTM) 32.83% 29.65% Auro Laboratories Limited
Return on Equity 4.28% 14.64% Divi's Laboratories Ltd.
Return on Assets (TTM) 1.86% 12.94% Divi's Laboratories Ltd.
Free Cash Flow (TTM) $-180.54M $2.15B Divi's Laboratories Ltd.
Dividend Yield N/A 0.91% N/A
1-Year Return 11.96% 0.83% Auro Laboratories Limited
Price-to-Sales Ratio (TTM) 5.48 16.18 Auro Laboratories Limited
Enterprise Value $2.03B $1,635.46B Divi's Laboratories Ltd.
EV/Revenue Ratio 7.13 15.86 Auro Laboratories Limited
Gross Profit Margin (TTM) 88.05% 63.71% Auro Laboratories Limited
Revenue per Share (TTM) $46 $388 Divi's Laboratories Ltd.
Earnings per Share (Diluted) $5.20 $93.66 Divi's Laboratories Ltd.
Beta (Stock Volatility) 0.09 0.19 Auro Laboratories Limited

Auro Laboratories Limited vs Divi's Laboratories Ltd. Stock Performance Analysis

Loading Price Chart...

AUROLAB
DIVISLAB

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Auro Laboratories Limited-1.52%-3.45%6.14%-8.81%2.74%7.86%
Divi's Laboratories Ltd.0.67%-3.25%-0.65%4.12%1.88%3.66%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Auro Laboratories Limited11.96%219.81%161.67%1,083.37%3,551.32%4,900.00%
Divi's Laboratories Ltd.0.83%89.86%56.44%484.44%1,625.50%9,907.51%

Performance & Financial Health Analysis: Auro Laboratories Limited vs Divi's Laboratories Ltd.

MetricAUROLABDIVISLAB
Market Information
Market Cap i₹1.56B₹1.69T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i4,557253,443
90 Day Avg. Volume i4,543283,911
Last Close₹262.90₹6,576.50
52 Week Range₹159.00 - ₹317.00₹5,636.50 - ₹7,071.50
% from 52W High-17.07%-7.00%
All-Time High₹317.00 (Feb 18, 2026)₹7,071.50 (Jul 08, 2025)
% from All-Time High-17.07%-7.00%
Growth Metrics
Quarterly Revenue Growth2.08%0.12%
Quarterly Earnings Growth37.27%-0.01%
Financial Health
Profit Margin (TTM) i0.11%0.24%
Operating Margin (TTM) i0.33%0.30%
Return on Equity (TTM) i0.04%0.15%
Debt to Equity (MRQ) i100.840.58
Cash & Liquidity
Book Value per Share (MRQ)₹70.01₹580.95
Cash per Share (MRQ)₹1.07₹122.95
Operating Cash Flow (TTM) i₹74.16M₹19.67B
Levered Free Cash Flow (TTM) i₹18.39M₹21.91B
Dividends
Last 12-Month Dividend Yield iN/A0.91%
Last 12-Month Dividend iN/A₹60.00

Valuation & Enterprise Metrics Analysis: Auro Laboratories Limited vs Divi's Laboratories Ltd.

MetricAUROLAB (Apr 26, 2026)DIVISLAB (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i48.0867.11
Forward P/E iN/A53.75
PEG Ratio i0.014.63
Price to Sales (TTM) i5.4816.18
Price to Book (MRQ) i3.5710.82
Market Capitalization
Market Capitalization i₹1.56B₹1.69T
Enterprise Value i₹2.03B₹1.64T
Enterprise Value Metrics
Enterprise to Revenue i7.1315.86
Enterprise to EBITDA i31.1448.63
Risk & Other Metrics
Beta i0.090.19
Book Value per Share (MRQ) i₹70.01₹580.95

Financial Statements Comparison: Auro Laboratories Limited vs Divi's Laboratories Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricAUROLAB (2025)DIVISLAB (2025)
Revenue/Sales i191.24M93.25B
Cost of Goods Sold i99.08M38.70B
COGS % of Revenue i51.8%41.5%
Gross Profit i92.16M54.55B
Gross Margin i48.2%58.5%
Research & Development iN/A270.00M
Operating Income (EBIT) i23.07M25.71B
Operating Margin i12.1%27.6%
EBITDA i40.60M33.19B
EBITDA Margin i21.2%35.6%
Pre-Tax Income i18.81M29.16B
Pre-Tax Income % of Revenue i9.8%31.3%
Income Tax i421,0007.25B
Income Tax % of Revenue i0.2%7.8%
Net Income (Profit) i18.39M21.91B
Profit Margin i9.6%23.5%

Balance Sheet & Liquidity Metrics

MetricAUROLAB (2025)DIVISLAB (2025)
Cash & Equivalents i3,0004.15B
Total Current Assets i215.14M100.81B
Total Current Assets % of Revenue i112.5%108.1%
Total Current Liabilities i216.42M14.52B
Total Current Liabilities % of Revenue i113.2%15.6%
Long-Term Debt i330.85M20.00M
Long-Term Debt % of Revenue i173.0%0.0%
Total Shareholders Equity i429.68M149.69B
Retained Earnings i359.52M134.00B
Retained Earnings % of Revenue i188.0%143.7%
Property, Plant & Equipment i16.55M3.19B

Cash Flow Statement Comparison

MetricAUROLAB (2025)DIVISLAB (2025)
Operating Cash Flow i74.16M19.67B
Operating Cash Flow % of Revenue i38.8%21.1%
Capital Expenditures i20,000-14.38B
Free Cash Flow i-180.54M2.15B
FCF Margin i-94.4%2.3%
Debt Repayment i0N/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricAUROLABDIVISLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i6.23M265.47M
Float Shares i2.35M117.72M
% Held by Insiders i60.96%52.04%
% Held by Institutions i0.00%28.65%
% Held by Public i39.04%19.31%

Dividend Analysis & Yield Comparison: Auro Laboratories Limited vs Divi's Laboratories Ltd.

MetricAUROLABDIVISLAB
Last 12-Month Dividend iN/A₹60.00
Last 12-Month Dividend Yield iN/A0.91%
3-Year Avg Annual Dividend iN/A₹50.00
3-Year Avg Dividend Yield iN/A0.70%
3-Year Total Dividends iN/A₹150.00
Ex-Dividend DateN/AJul 25, 2025